FDA approves new treatment for a rare genetic disorder, Fabry disease - FDA Press Releases

FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

from Food and Drug Administration--Press Releases https://ift.tt/2AXABmc
via IFTTT